Tradestie Institutional Equity Comparison Engine

VRTX vs DXCM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DXCM Overall Edge

DXCM Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Momentum & Technical, Options & Structure while VRTX counters with relative strength in Growth & Margin. Fundamentally, VRTX trades at 25.9x Forward P/E with 37.8% operating margin (+11.8% YoY revenue) versus DXCM at 25.3x Forward P/E and 24.0% operating margin (+11.2% YoY). In options structure, VRTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DXCM
VRTX 25.9x vs DXCM 25.3x Fwd P/E
Growth & Margin Winner VRTX
Op Margin 37.8% vs 24.0% ยท YoY +11.8% vs +11.2%
Momentum & Technical Winner DXCM
1Y +22.3% vs +32.8% ยท 52W Pos 66% vs 63%
Options & Structure Winner DXCM
CONSOLIDATION (33rd %ile IV) vs CONSOLIDATION (15th %ile IV)
VRTX NASDAQ
Vertex Pharmaceuticals Inc
Pharmaceutical Preparations
$515.02
-1.08% 1D
Market Cap $132.0B
1M Return -3.77%
1Y Return +22.32%
Forward P/E 25.9x
Unified AI Score
40.9 / 100 SELL
Tech 25.0 Fund 47.0 Flow 69.0 Mom 46.0
DXCM NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$79.32
-1.08% 1D
Market Cap $29.9B
1M Return +1.28%
1Y Return +32.8%
Forward P/E 25.3x
Unified AI Score
50.8 / 100 HOLD
Tech 49.0 Fund 56.0 Flow 68.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VRTX +22.32% DXCM +32.8% Spread: +10.48 pp (DXCM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VRTX Revenue DXCM Revenue VRTX Op. Margin DXCM Op. Margin Margin Edge
FY2018 $3.05B $1.03B 20.8% -18.1% VRTX
FY2019 $4.16B $1.48B 28.8% 9.6% VRTX
FY2020 $6.21B $1.93B 46.0% 15.5% VRTX
FY2021 $7.57B $2.45B 36.7% 10.9% VRTX
FY2022 $8.93B $2.91B 48.2% 13.4% VRTX
FY2023 $9.87B $3.62B 38.8% 16.5% VRTX
FY2024 $11.0B $4.03B -2.1% 14.9% DXCM
FY2025 $12.0B $4.66B 34.8% 19.6% VRTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VRTX (6) vs DXCM (4)
Institutional Metric VRTX DXCM Criterion Row Winner
Market Capitalization Scale $132.0B $29.9B Larger Scale VRTX
Trailing P/E Ratio Valuation 33.5x 31.6x Lower Multiple DXCM
Forward P/E Ratio Valuation 25.9x 25.3x Lower Multiple DXCM
Revenue Growth (YoY) Growth +11.8% +11.2% Higher Growth VRTX
Operating Margin (TTM) Profitability 37.8% 24.0% Higher Margin VRTX
Net Profit Margin Profitability 30.7% 19.4% Higher Margin VRTX
Return on Equity (ROE) Capital Efficiency 20.8% 37.7% Higher ROE DXCM
52-Week Range Position Momentum 66% ($412โ€“$569) 63% ($57โ€“$93) Stronger Trend VRTX
Beta / 30D Volatility Risk Regime 0.35ฮฒ ยท 28% Vol 0.59ฮฒ ยท 43% Vol Lower Realized Risk VRTX
Unified Institutional Score Composite Signal 40.9 / 100 (SELL) 50.8 / 100 (HOLD) Higher Composite DXCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VRTX vs DXCM Buy Guide
VRTX CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VRTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DXCM CONSOLIDATION
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live DXCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VRTX nor DXCM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.